The current 'mononuclear phagocyte system' model 1 has guided many investigators studying the functions of macrophages over the past 30 years. It postulates that tissue macrophages are maintained from a constant supply of bone marrow-derived circulating blood monocytes that extravasate into tissues 2 . This model was initially based on the observation that blood leukocytes recruited into the inflamed peritoneum differentiate into macrophages. Subsequent experiments of transplantation into irradiated recipients demonstrated that bone marrow hematopoietic stem cells (HSCs) and HSC-derived myeloid progenitors can indeed give rise to tissue macrophages or dendritic cells in mice and humans [3] [4] [5] [6] [7] . Therefore, investigations designed to study the molecular and cellular basis of macrophage phenotypic diversity and function have focused largely on the activation or polarization of monocyte-derived macrophages by external cues, such as cytokines and microbe-associated signals [8] [9] [10] . Nevertheless, it remains unclear whether the polarization stages of monocytes are stable or represent transient states of activation, whether they account for the phenotypic and functional heterogeneity of macrophages in vivo in health or disease states, and how many such polarized states exist 10, 11 .
A new model of macrophage development is emerging that is based on many independent observations that two distinct populations of macrophages, which can be distinguished by their progenitors, developmental history, turnover and mechanisms of maintenance, coexist within the tissues of an adult mouse. The macrophage system of a mouse can now be described as a 'layered' system in which 'resident' macrophages that develop in embryos independently of HSCs 12 persist in adult tissues independently of adult HSCs [12] [13] [14] [15] [16] [17] [18] and coexist with 'passenger' leukocytes, such as monocytes and classic dendritic cells, that originate and renew from bone marrow HSCs and myeloid progenitors 4, 6, 19 . Tissue-resident macrophages include spleen red-pulp macrophages, lung alveolar macrophages, epidermal Langerhans cells, brain microglia, liver Kupffer cells, large peritoneal macrophages, and F4/80 bright pancreatic, kidney and cardiac macrophages. Many tissue-resident macrophages are long lived in mice and can proliferate within their tissue of residence, a mechanism involved in their maintenance in adults [20] [21] [22] [23] [24] [25] [26] [27] . Nevertheless, bone marrow-derived progenitor cells also contribute to subsets that reside in the lamina propria, spleen, brain, skin, heart, liver and kidneys in a proportion that varies by tissue, mouse age and pathological processes [12] [13] [14] [15] [16] [17] [18] 28, 29 .
Therefore, the purpose of this Review is to present and discuss current knowledge of the developmental biology of resident macrophages, as it underlies the concept of a layered myeloid system composed of tissueresident macrophages distinct from passenger macrophages and myeloid cells and provides a new framework and experimental tools with which to characterize the functions of macrophages in vivo, in health and in disease settings.
The original concept of 'primitive macrophages' During ontogeny, macrophages are found in the mouse yolk sac and the embryo before the initiation of HSC-derived hematopoiesis and before monocytes can be detected in the fetal blood. These 'primitive macrophages' were described in a series of seminal works 20, 30, 31 that reported the presence of large cells with macrophage morphology in blood islands of the yolk sac at embryonic day 9 (E9) and in the fetal liver at E10. These were described as 'immature' because of their lack of detectable phagocytic activity and weak immunoreactivity for the macrophage marker F4/80, as detected by electron microscopy 20, 30 . In addition to reporting those 'immature macrophages' , these early studies also reported the existence of 'fetal macrophages' from E10 to E17 as slightly smaller cells with pseudopodia, phagocytic activity and frequent mitotic figures 31 . At E17, the 'fetal macrophages' were reported as more differentiated, as they acquired ultrastructural features similar to those of adult tissue macrophages 30, 32 . These early studies noted that the remaining difference between fetal tissue macrophages and adult tissue macrophages was the presence of numerous mitotic figures in fetal macrophages throughout development. It was also noted that poorly differentiated myeloid cells were detected in the blood vessels of the yolk sac at E10 (ref. 20) , and immature stages of the region) in which they are generated, expand and differentiate, their differentiation potential and their dependence on transcription factors (Table 1 and Fig. 1) . Here we will focus on the myeloid lineages; erythroid lineages have already been reviewed 37 .
Primitive hematopoiesis as a source of macrophages in embryos Primitive hematopoiesis is the source of the first hematopoietic cells detected in the developing embryo. It is characterized by the emergence of progenitor cells with limited potential for development into erythrocytes and macrophages and that can be found in the extra-embryonic yolk-sac blood islands in mice 36 . These progenitor cells are thought to arise directly from the posterior plate mesoderm, and clonal analysis of the blood islands has revealed that the endothelial cells lining the blood islands and the hematopoietic cells they contain do not share a common origin 38 . This distinguishes them from the subsequent 'definitive' hematopoietic waves, which are thought to arise from a hemogenic endothelium. Accordingly, primitive progenitors and their daughter cells are not affected when transcription factors required for the endothelial-hematopoietic transition, such as Runx1, are absent ( Table 1) .
In zebrafish embryos, the 'primitive' wave can give rise to erythrocytes and macrophages, as well as neutrophils, in the absence of the gene encoding Runx1 (refs. 39-41) . In the mouse embryo, in vivo characterization of the macrophage progeny of the primitive wave is still hampered by experimental constrains. However, (rare) progenitors with restricted macrophage potential in vitro can be found in the yolk sac at the neural-plate stage between E7.5 and E8 (refs. 34,36) . monocyte and neutrophil differentiation series could be detected from E12 onward, and finally true neutrophils and monocytes, identified on the basis of ultrastructural features and endogenous peroxidase-cytochemistry, were present in the fetal liver at E15 and E16, respectively 30 . These researchers therefore proposed that fetal macrophages develop without a monocytic intermediate and in parallel with the monocyte and granulocyte lineage.
In subsequent literature, that early work was sometimes reported as evidence of the early colonization of the fetus by 'yolk-sac macrophages' before their replacement by monocyte-derived macrophages. However, this body of work described the identification of proliferating non-phagocytic precursors of macrophages (described as 'immature macrophages') that originate in the yolk sac, colonize the embryo and finish their differentiation in situ within the fetal tissues 20, 30, 31 . This description did not correspond to a particular wave of hematopoietic progenitors ('primitive' or 'definitive'), as discovered subsequently. However, the description of erythro-myeloid progenitors (EMPs) [33] [34] [35] [36] (discussed below) and additional fate-mapping data are in accordance with the original interpretation of the morphological data. Indeed, genetic pulse labeling of Csf1r-positive c-Kit + CD45 lo AA4.1 + EMPs present in the yolk sac at E8.5 is followed by the detection of labeled CD11b + cells with negative or faint immunoreactivity for F4/80 at E9.5 in both the yolk sac and embryo and then by the detection of F4/80 bright cells starting from E10. 5 (ref. 18) .
More recent work has identified three successive but overlapping waves of hematopoietic progenitors during development, all of which have the potential to give rise to fetal macrophages 34 . These can be distinguished by the anatomical site (extra-embryonic yolk sac versus intra-embryonic The surface phenotypes, ability to self-renew, anatomical sites of origin, expansion and differentiation, expression and dependence on transcription factors of various progenitor cells. MP, myeloid progenitor; YS, yolk sac; FL, fetal liver; BM, bone marrow; TF, transcription factor; NA, not applicable.
*Red blood cell differentiation is compromised. **Macrophage differentiation is compromised.
has been described elsewhere 52, 53 . HSCs and EMPs arise from distinct hemogenic endothelial cells 43 . HSCs emerge from the hemogenic endothelium of the aorto-gonado-mesonephros (AGM) region (starting at E10.5 in mice) 39, 54, 55 and of the umbilical and vitelline arteries 56 and migrate to the fetal liver, where they expand and differentiate from E12.5 until definitive hematopoiesis begins to shift to the bone marrow. HSCs colonize the embryonic bone marrow at E15, and active hematopoiesis starts there at E17 (refs. 47,57) . Fetal and adult HSCs require c-Myb for their self-renewal and maintenance, and loss of c-Myb expression leads to rapid HSC-derived hematopoiesis failure 12, [58] [59] [60] . In addition, HSCs also require the transmembrane receptor Notch1 for their emergence, in contrast to EMPs, as Notch1 -/-embryos have normal numbers of hematopoietic progenitor cells in the yolk sac but very few in the body of the embryo 61 . Several groups have attempted to pinpoint the specific site and time at which HSCs can be first detected within the embryo proper. Pioneering work demonstrated that the AGM region contains the progenitor cells endowed with long-termrepopulating ability at E10. 5 (ref. 62) . However, immature HSCs have been detected at E9-E9.5 in the para-aortic splanchnopleura, a structure that later evolves into the AGM region. Such immature HSCs migrate into the fetal liver at E10, mature into HSCs and contribute to the adult HSC pool 47 .
Genetic models distinguish the three progenitor waves As described above, the emergence of different waves of hematopoietic precursor cells partially overlaps in a short time frame, which has made fate-mapping difficult. However, these precursor cells can be distinguished genetically, and overall, the layering of the hematopoietic system and in particular of macrophage development seems to stand on a robust genetic basis. Primitive hematopoiesis occurs in the absence of Runx1 and c-Myb 63, 64 , while EMPs are dependent on Runx1 for their emergence 64 but are independent of c-Myb for their myeloid differentiation 12, 18, 49 and are Notch1 independent 61 . In contrast, fetal and adult HSCs require Runx1, c-Myb and Notch1 (refs. 39,40,58,59,61) ( Table 1) . On the basis of these data, several reports have investigated the lineage of origin of fetal (primitive) and adult macrophages and the mechanisms that might account for their persistence in adults. 42 . However, they can be distinguished from HSCs by their lack of lymphoid potential, both in vitro and in vivo, their lack of long-term repopulating potential 35 and lack of surface expression of the lineage marker Sca-1 (ref. 35 ). EMP-derived hematopoiesis is sufficient to support survival of HSCdeficient embryos until birth 43 . EMP emerge from the yolk-sac hemogenic endothelium in a Runx1-dependant endothelial-to-hematopoietic transition 44 . The emergence of EMPs from the yolk sac does not require blood flow, as indicated by results obtained by the study of embryos deficient in the sodium-calcium exchanger NCX1 or VE-cadherin 35, 45, 46 . They are generated from Tie2 + yolk-sac ancestors from E7.5 to E10. 18 . EMPs isolated from the yolk sac at E8.5 and the fetal liver at E12.5 have the same differentiation potential in vitro, but erythroid, monocyte and granulocyte and mast-cell potential is observed in vivo only after seeding of the fetal liver 18 . Thus, the fetal liver niche provides critical cues or an environment for EMPs to reach their full potential. Yolk-sac EMPs express the gene encoding the transcription factor c-Myb (Myb) 48 , but their commitment and differentiation into the myeloid fate is unaltered in c-Myb-deficient embryos, although their erythroid potential is blocked 12, 18, 49, 50 (Table 1) . Therefore, c-Myb is required for the commitment and differentiation of EMPs into the erythroid fate 50 but is dispensable for myeloid differentiation and is possibly redundant for this, because EMPs express the gene encoding b-Myb (Mybl2), a transcription factor that can restore hematopoiesis in c-Myb-deficient Drosophila melanogaster 51 . embryo 18 , while EMP-derived macrophages persist all through fetal and post-natal development as tissue-resident macrophages 12, 18 (Fig. 2) . It has also been speculated that a first wave of c-Myb-independent EMPs gives rise to microglia and a second wave of c-Myb-dependent EMPs gives rise to other macrophages 67 . However, there are no data available to support the proposal of the existence of two genetically distinct populations of EMPs, and this hypothesis is not in accordance with reports that c-Myb is expressed in early yolk-sac EMPs 36, 48 or with the persistence of fetal resident macrophages in all c-Myb-deficient embryonic tissues 12 .
Resident macrophages originate mainly from yolk-sac EMPs
The contribution of 'primitive' hematopoiesis to microglia Primitive hematopoiesis could also contribute to 'primitive' and fetal macrophages. Early pulse labeling of progenitor cells (at E7.5) with several different reporters, such as Runx1, CSF1R, Tie2 and c-Kit 12, 14, 18, 70 , results in more efficient labeling of adult microglia than of other adult tissue-resident macrophages. As mentioned above, this might relate either to earlier termination of colonization of the brain by macrophages than that of other progenitor cells 12 . In addition, adult tissue-resident F4/80 bright macrophages have been traced back to c-Myb-independent precursor cells expressing the cytokine receptor CSF1R and present in the early mouse embryo at E8.5, as assessed through the use of Cre recombinase-mediated, hydroxytamoxifen-induced pulse labeling 65, 66 of transgenic mice expressing a tamoxifen-inducible fusion protein of 'improved' Cre recombinase (iCre) and the mouse estrogen receptor (Mer-iCre-Mer) under control of the macrophage-specific mouse gene encoding CSF1R 12 (discussed below). The data noted above would suggest that F4/80 bright macrophages originate not from HSCs but from yolk-sac progenitor cells such as either primitive progenitor cells or EMPs 48 . In accordance with that, brain microglia develop from yolk-sac progenitor cells 14 that have been functionally identified as EMPs 48 . Following pulse labeling of CSF1R-expressing cells with hydroxytamoxifen at E8.5 (in the mouse model described above), the labeling efficiency of F4/80 bright macrophages is 30% at day 10.5 and remains high (~20%) in microglia but progressively decreases from E12.5 onward in other organs to reach a plateau at birth that is maintained even in 1-yearold mice (5% for the liver Kupffer cells; 1% for epidermal Langerhans cells) 12, 18, 67 (data not shown). This might be explained by the observation that pulse labeling with hydroxytamoxifen at E8.5 labels only the very first EMPs that emerge in the yolk sac, while EMPs continue to emerge in the yolk sac until at least E10.5 (ref. 18) , and therefore the frequency with which the macrophages are labeled in embryonic tissues might reflect the time at which their colonization by fetal macrophages is completed. However, it is also possible that this 'dilution' reflects a contribution by another progenitor cells, such as fetal HSCs or HSC-derived monocytes, to several fetal macrophage populations 17, [67] [68] [69] . A contribution by fetal monocytes is unlikely, as they also derive from EMP until E16. 5 (refs. 18,35) . However, a contribution by fetal HSCs is still under debate 17, [68] [69] [70] .
The main argument against the possibility of a substantial contribution by fetal HSCs has been provided by experiments with a fate-mapping mouse model in which the expression of Cre recombinase (as the MeriCre-Mer fusion) is inducible in cells expressing the tyrosine kinase Tie2 (encoded by Tek) 18, 71 . Tie2 is expressed in the hemogenic endothelium, endothelial cells and hematopoietic progenitor cells in the yolk sac 72 , AGM region, fetal liver HSCs and adult HSCs 52 . Pulse labeling of these mice with tamoxifen at E7.5, E8.5, E9.5 and E10.5 results in the labeling of adult HSCs, lymphocytes, monocytes and neutrophils with the same efficiency, as expected. In contrast, fetal macrophages and adult tissueresident F4/80 bright macrophages in all organs are labeled with a decreasing efficiency (high at E7.5 to very low at E10.5), which indicates that fetal and adult F4/80 bright macrophages originate mainly from a progenitor cell that does not express Tie2 after E10.5, with a minor contribution of progenitor cells (such as HSCs) that express Tie2 after E10.5.
Research with fate-mapping models in which the expression of Cre recombinase is either inducible (as the Mer-iCre-Mer fusion) or constitutive (iCre alone) in CSF1R-expressing cells has identified the macrophage progenitor itself as a CD45 lo Kit + AA4.1 + EMP that appears in the yolk sac from E8. 5 (ref. 18) . These EMPs migrate into the fetal liver, where they expand and persist as c-Kit + progenitors until at least E16. 5 (ref. 18) . These EMPs give rise to erythrocytes, monocytes, granulocytes and mast cells until late in fetal development 18, 35 , in accordance with the observation that HSC-independent hematopoiesis is not only necessary but also sufficient to support the survival of HSC-deficient embryos until birth 43 . These EMPs also give rise to F4/80 bright fetal macrophages in all embryonic tissues from E10.5 onward 18 . An EMP origin of the majority of tissue-resident macrophages has also been favored in an independent report 67 .
Together, the data reported above support the proposal of a major contribution of yolk-sac EMPs to fetal and adult resident macrophages ( Figs. 1 and 2) . EMP-derived erythrocytes, monocytes, granulocytes and mast cells are ultimately replaced by HSC-derived myeloid cells in the late originate from a macrophage-restricted, self-renewing progenitor cell in bone marrow that does not give rise to any other lineage 73 . These findings, if confirmed, would indicate that myelopoiesis in birds is markedly different from its counterparts in mice, zebrafish and human, because a macrophage-restricted, self-renewing progenitor cell in the bone marrow or its equivalent has not been identified in these species.
Maintenance of macrophages by local proliferation or recruitment As indicated above, a proportion of alveolar macrophages, kidney macrophages and heart macrophages seem to be replaced during the normal aging process 12, 18, 75 . Partial replacement of tissue-resident macrophages is also observed following g-irradiation, bone marrow transplantation or adoptive-transfer experiments 3,4,77 and in macrophage-depletion studies, such as intravenous injection of clodronate liposomes. Liver Kupffer cells are also reported to be replaced by bone marrow-derived progenitor cells following, for example, the death of Kupffer cells in severe experimental infection with Listeria monocytogenes 29 . However, resident macrophages such as Langerhans cells, Kupffer cells, microglia, alveolar macrophages, peritoneal macrophages and splenic macrophages all have the potential to proliferate 15, 22, 23, 27, [78] [79] [80] [81] [82] . In some cases, tissue-resident macrophages can immediately replenish themselves following severe depletion 15, 23, 82 . A growing body of evidence now clearly shows that fully differentiated resident macrophages can re-enter the cell cycle and maintain their numbers by local proliferation [23] [24] [25] [26] [27] . Macrophage proliferation increases substantially during inflammatory conditions, such as skin inflammation, during which up to 30% of Langerhans cells express the proliferation marker Ki67 (ref. 22) . During an acute inflammatory response, the tissueresident peritoneal macrophages that survive undergo a transient and intense proliferative burst in situ to repopulate the tissue 23 . In response to helminth infection, macrophages residing in the pleural and peritoneal cavities expand by local proliferation 81 . In glucan-induced formation of granulomas in monocytopenic mice, Kupffer cells proliferate actively and contribute to granuloma formation 78 . After conditional ablation of microglia in adult mice, the microglial compartment is reconstituted within 1 week by cells residing in the central nervous system, independently of bone marrow-derived precursor cells 82 . However, it remains unclear whether the tissue-resident macrophage populations contain a local 'progenitor compartment' or whether all macrophages have the ability to undergo mitosis. The mechanisms that underlie this ability of tissue-resident macrophages to self-maintain and to proliferate are still unclear. An important role for the Maf family of transcription factors is likely, as combined deficiency in MafB and c-Maf enables the KLF4-and c-Myc-dependent proliferation of differentiated macrophages in culture in response to the cytokine CSF1 (M-CSF) 83 . In epidermal Langerhans cell, proliferation in vivo has been shown to be driven by an unidentified keratinocyte-derived signal 22 . During nematode infection, macrophage proliferation is impaired in the absence of interleukin 4 (refs. 81,84) . The cellular and molecular mechanisms that control macrophage maintenance and expansion in adult mice, and the consequences of aging on these processes, are an area of active investigation, as their elucidation will shed light on the pathophysiology of inflammation.
Conclusions and perspectives on macrophage function
A revised model for macrophage development and function is therefore emerging that distinguishes the tissue-resident macrophages that develop during embryogenesis from the passenger myeloid cells that originate and undergo renewal from bone marrow HSCs. This distinction between passenger macrophages and tissue-resident macrophages is in line with early kinetic studies of the splenic-myeloid compartment in adult mice, which proposed a dual origin for myeloid cells, with half of myeloid cells renewing from blood and the other half being produced within the organs or to the existence of several subsets of EMPs. However, it might also reflect the contribution of primitive hematopoiesis to microglia. Future studies should determine whether primitive progenitor cells are labeled in these models and should investigate whether macrophages produced by primitive hematopoiesis can persist in adult mice. Independence of c-Myb does not allow genetic distinction of primitive hematopoiesis from EMP-derived hematopoiesis, and it is not yet known whether Runx1 is required for the differentiation of macrophages in mice. Together, the lack of genetic delineation and the low temporal resolution of classic fatemapping approaches in the mouse have not yet allowed independent tracking of the respective progeny of the two progenitor populations. Better understanding of the molecular control of primitive progenitor cells and the commitment and differentiation of EMPs is needed for the development of better tools for characterization of the possible contribution of 'primitive' hematopoiesis to the development of fetal macrophages and, possibly, adult macrophages in mice.
Contribution of HSCs depends on organ and time
Analysis of the contribution of HSCs to adult resident macrophages in the absence of bone marrow irradiation has been performed by several groups studying mice expressing Cre recombinase from the gene encoding the receptor tyrosine kinase Flt3 (Flk2) (refs. 12,17,18,73) , on the basis of the observation that Flt3 is expressed by HSC-derived progenitor cells 71, 74 but not by fetal macrophages 12 . The contribution of HSCs has also been studied in several independent models of bone marrow transplantation without irradiation, such as Myb fl/fl Mx1-Cre mice (which undergo deletion of loxP-flanked Myb alleles (Myb fl/fl ) via Cre expressed from the interferon-inducible gene Mx1) and Kit W/Wv Rag2 -/-Il2rg -/-mice (which lack mast cells and have hypoplastic bone marrow (Kit W/Wv ) and lack lymphocytes (Rag2 -/-Il2rg -/-)) 12, 18 and in parabiotic mice 15, 75 . Overall, these analyses have revealed that the contribution of HSCs to tissue-resident macrophages differs among organs and frequently increases with age. The contribution of HSCs to adult tissue-resident macrophages is minor (<5%) in the brain, liver and epidermis 12, 14, 48 , is small but increases with age in the lungs, heart and spleen 18, 75 , and sometimes predominates after weaning in gut lamina propria 28, 76 (Figs.  1 and 2) . It is not yet known whether the precursor(s) of the HSC-derived resident macrophages is (are) the monocyte or earlier myeloid progenitor, except in the gut, in which Ly6C + monocytes are proposed to be the immediate precursor of gut lamina propria macrophages 28, 76 .
Of note, a published report has investigated the origin of tissue-resident macrophages through the use of a fate-mapping model in which the expression of Cre recombinase (as Mer-iCre-Mer) is inducible in cells expressing the gene encoding the stem-cell-factor receptor c-Kit (CD117) (ref. 70) . Notably, this study represents independent confirmation of the finding that most adult tissue-resident macrophages originate from embryonic and fetal progenitor cells and persist in adults independently of adult HSCs, as c-Kit + progenitor cells do not seem to contribute to tissue-resident macrophages after E16. 5 (ref. 70) . The authors also conclude that most tissue-resident macrophages, except microglia, are descendants of fetal HSCs, not EMPs, on the basis of the observation that labeling of c-Kit + Sca-1 + EMPs at E7.5 results in the labeling of microglia only, while labeling of c-Kit + progenitor cells at E8.5 or E9.5, in contrast, results in the labeling of all adult resident macrophages and HSC-derived cells 70 . However, EMPs do not express Sca-1 (ref. 35) (Table 1) , while EMPs and fetal HSCs both express c-Kit and co-exist in the fetal liver until E16. 5 (refs. 18,35) . Thus, c-Kit expression and c-Kit-based fate mapping might not allow the distinction of EMPs versus fetal HSCs.
Studies of chickens have suggested that in contrast to results obtained for mice, yolk sac-derived macrophages are not retained in chickens after hatching and, surprisingly, that tissue macrophages in the adult birds spleen 85 . It also explains the observations that Langerhans cells do not undergo exchange between parabiotic mice 13 and that fetal microglia persist in adult mice 14 .
That distinction is relevant to disease pathogenesis, as it is apparent that the functions of HSC-derived monocytes can be very different from those of tissue-resident macrophages in the same inflammatory environment. The two cell types have distinct expansion mechanisms and distinct functions in the brain during experimental autoimmune encephalitis 86 . Infiltrating monocytes are recruited via extravasation from blood vessels and produce inflammatory mediators important for disease progression but do not persist after the resolution of inflammation, while, in contrast, activated resident microglia proliferate locally, persist and return to quiescence following remission 86 . Following parasitic helminth infection, pleural resident macrophages adopt anti-inflammatory phenotypes, while passenger macrophages exhibit pro-inflammatory responses 81 . However, in a model of chronic neurodegeneration, proliferating resident microglial cells contribute to neuronal damage during development of the disease 87 . Thus, it might be inaccurate to describe tissue-resident macrophages as always being 'anti-inflammatory' in contrast to passenger macrophages that are always 'pro-inflammatory' . The respective roles of tissue-resident macrophages and passenger macrophages remain to be studied in detail, and most experimental models available at present do not allow easy elucidation of the roles of resident and recruited macrophages in adult mouse tissues. Future work should help characterize the roles of (EMP-derived) tissue-resident macrophages, separate them from the functions of HSCderived passenger macrophages and characterize the underlying molecular mechanisms involved.
It is also important to recognize that the distinct subsets of resident macrophages associated with different tissues, such as microglia, Langerhans cells, Kupffer cells, peritoneal macrophages, red-pulp macrophages and alveolar macrophages, have different phenotypes, transcriptional profiles and chromatin 'landscapes' 88, 89 , require specific growth factors, and rely on distinct transcription factors for their differentiation or maintenance. For example, CSF1 is essential for Kupffer cells 90 , the growth factor TGF-b1 and interleukin 34 are essential for microglia and Langerhans cells 88, [91] [92] [93] , CSF2 (GM-CSF) is essential for alveolar macrophages in mice and humans [94] [95] [96] [97] [98] [99] , and retinoic acid and the transpiration factor GATA-6 are essential for large peritoneal macrophages 88, 100, 101 . The transcription factor Spi-C is important for the development of red-pulp macrophages 102 , while mice deficient in the nuclear receptor LXR are defective in the generation of marginal-zone and metallophilic macrophages 103 .
Tissue-specific environments are important for the maintenance of macrophage identity 88, 89 . Several studies also suggest that individual resident macrophage subsets follow a differentiation program during embryogenesis and early post-natal life that results in the establishment of stable phenotypic and functional subsets 22, 48 . Future work investigating the respective contributions and interplay of lineage-specific 'hard-wired' differentiation programs and of the local tissue micro-environment to the differentiation, maintenance and activation of tissue-specific resident macrophages will contribute to the understanding of their functions.
